Tag: anti-obesity drugs

Market News

Eli Lilly Foundayo Pill Production Surge And Obesity Market Race

Lilly says one-third of new GLP-1 pill patients already choose Foundayo, while a $6.5 billion plant is only the start....

21/09/2026

11 views

Read More

Market News

Novo Stock Falls Despite $23 Billion Obesity Drug Target

Novo just promised more than five multi-blockbuster drugs and $23 billion in pipeline sales. The stock still fell as much...

21/09/2026

11 views

Read More

Market News

Lilly Obesity Windfall Fuels Deals As Oil Lifts Energy

Lilly is recycling obesity profits into another biotech buyout while oil jumps and Musk rattles turbine suppliers. The last hour...

31/08/2026

11 views

Read More

Market News

Eli Lilly Stock Hits Record Highs As Investors Book Massive Gains

One major drug maker just delivered a five-fold profit as shares hit fresh records. A long-held position is being trimmed...

19/08/2026

13 views

Read More

Market News

Eli Lilly Retatrutide Set for 2027 Approval After Strong Trial Results

Eli Lilly just announced big progress on its next-generation obesity drug retatrutide, with impressive weight loss numbers from the latest...

23/07/2026

12 views

Read More

Market News

Medicare Obesity Drug Coverage Begins: What Seniors Need to Know Now

Millions of seniors are about to gain access to powerful weight loss medications through Medicare for the first time ever,...

30/06/2026

8 views

Read More

Market News

Medicare Obesity Drug Coverage Starts Soon: What Seniors Must Know Now

Millions of older Americans are on the verge of accessing game-changing obesity treatments through Medicare for just $50 a month...

28/06/2026

9 views

Read More

Market News

Obesity Drugs Hit Major Milestone With Lilly Game Changer Ahead

Obesity medications are crossingPlanning the article structure and title a historic threshold with new coverage options and next-generation therapies on...

25/06/2026

13 views

Read More

Market News

Why Jim Cramer Won’t Sell Eli Lilly Despite Huge Stock Run

Jim Cramer just admitted he can't bring himself to sell Eli Lilly even after a parabolic run to record highs....

08/06/2026

10 views

Read More

Market News

Weight Loss Drug Stock Crashes 25% on Alarming Safety Data

Shares of a major weight loss drug developer just dropped over 25% in a single day after fresh safety data...

08/06/2026

7 views

Read More